In 2014, in a review of the evidence, the American Academy of Neurology concluded that bee venom therapy is possibly ineffective for relapses, disability, fatigue, lesion burden and health related quality of life (QoL). In 2008, a review of non-conventional approaches to treating MS found that there was only marginal evidence for bee venom therapy. Although this study found the therapy was safe, the small number of people involved meant it was not possible to draw conclusions about whether it was effective. After 24 weeks, no difference was found between the two groups on any of these measures.Īnother small study looked at the use of honeybee venom with people with progressive MS. Results were measured using MRI scans, relapse rate, disability, fatigue and quality of life scales. In 2005 a small clinical trial compared people having the therapy every week with a group that had no treatment. There has been very little medical research to support bee venom therapy. It is suggested that this benefits people with a range of conditions including MS. This leads to an anti-inflammatory response by the immune system. The theory behind the treatment is that bee stings cause inflammation. There may be more than one session per week. Ice is used to numb the skin and to reduce pain. Therapy with bee venom involves receiving up to 40 stings in a session. There is no research to show it is an effective treatment for people with MS. Pharmaceutical and other industry supportersĪpitherapy (bee venom therapy) is the medicinal use of bees or bee products.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |